This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: **Innovative Contributions of Jimmy Arnold Viviene Van Heusden**
Introduction
Jimmy Arnold Viviene Van Heusden, based in Oelegem, Belgium, is a recognized inventor in the field of medicinal chemistry. He has made significant contributions through his innovative work, particularly in developing novel compounds that serve as potential therapeutic agents. His research emphasizes the importance of histone deacetylase inhibitors, which hold promise for various medical applications.
Latest Patents
Van Heusden is the inventor of a notable patent titled "Sulfonyl-derivatives as novel inhibitors of histone deacetylase." This invention involves novel compounds of formula (I), which possess defined roles indicated by variables such as n, m, t, R, L, Q, X, Y, Z. These compounds exhibit histone deacetylase inhibiting enzymatic activity. The patent encompasses their preparation, composition, and potential usage as medicinal products.
Career Highlights
Jimmy Arnold Viviene Van Heusden's career is distinguished by his role at Janssen Pharmaceutica NV, a prominent pharmaceutical company known for its focus on innovation and research. His work has contributed greatly to the advancement of therapies that target debilitating diseases through mechanism-based approaches.
Collaborations
In the course of his career, Van Heusden has collaborated with talented professionals, including Kristof Van Emelen and Janine Arts. These partnerships highlight the collaborative spirit within the research community and reflect the importance of teamwork in driving innovation forward.
Conclusion
Jimmy Arnold Viviene Van Heusden illustrates the impact that dedicated inventors can have on healthcare through their innovative contributions. His patent on sulfonyl-derivatives showcases the potential for new therapeutic avenues in the treatment of disease, making a significant mark in the field of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
